Comment by
Starkicker on Apr 29, 2024 9:30am
I'm going to be watching the Q1 numbers and report closely in a couple of weeks. If there isn't a significant uptick in revenue I'll reasses my interest in this company. When management says things like they did back in November then nothing happens, I have to question their authenticity and my investment.
Comment by
subaru1i on Apr 29, 2024 9:41am
TWO, 2, FDA approvals. One for generic Epidiolex as already mentioned by CEO to be launched in the U.S. and 1 for 'new drug', the 505(b)2. TWO FDA APPROVALS.